Salona Global Medical Device Corporation announced preliminary revenue results for the fourth quarter ending February 28, 2022. Revenues (preliminary, pre-audit) increased from $5,286,702 to roughly $8,029,000 or a 52% increase from last quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 CAD | 0.00% | -13.21% | +9.52% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.52% | 13.22M | |
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
+0.30% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |
- Stock Market
- Equities
- BRTL Stock
- News Evome Medical Technologies Inc.
- Salona Global Medical Device Corporation Announces Preliminary Revenue Results for the Fourth Quarter Ending February 28, 2022